Related Experiment Video
Updated: May 13, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Allosteric regulation of serine protease HtrA2 through novel non-canonical substrate binding pocket
Pruthvi Raj Bejugam1, Raja R Kuppili, Nitu Singh
1Advanced Centre for Treatment, Research and Education in Cancer ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai, India.
Abstract:
HtrA2, a trimeric proapoptotic serine protease is involved in several diseases including cancer and neurodegenerative disorders. Its unique ability to mediate apoptosis via multiple pathways makes it an important therapeutic target. In HtrA2, C-terminal PDZ domain upon substrate binding regulates its functions through coordinated conformational changes the mechanism of which is yet to be elucidated. Although allostery has been found in some of its homologs, it has not been characterized in HtrA2 so far. Here, with an in silico and biochemical approach we have shown that allostery does regulate HtrA2 activity. Our studies identified a novel non-canonical selective binding pocket in HtrA2 which initiates signal propagation to the distal active site through a complex allosteric mechanism. This non-classical binding pocket is unique among HtrA family proteins and thus unfolds a novel mechanism of regulation of HtrA2 activity and hence apoptosis.
Insights
HtrA2 (High temperature requirement A2) protease activity is regulated by a novel allosteric mechanism. A unique binding pocket initiates signals to the active site, offering new therapeutic strategies for cancer and neurodegenerative diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- HtrA2 (High temperature requirement A2) is a proapoptotic serine protease implicated in cancer and neurodegenerative diseases.
- Its C-terminal PDZ domain regulates function via conformational changes, but the mechanism remains unclear.
- Allosteric regulation has been observed in HtrA2 homologs but not yet characterized in HtrA2 itself.
Purpose of the Study:
- To investigate the presence and mechanism of allosteric regulation in HtrA2.
- To identify novel regulatory sites and understand their role in HtrA2 function.
- To explore HtrA2 as a therapeutic target by elucidating its regulatory mechanisms.
Main Methods:
- In silico computational modeling.
- Biochemical assays to validate computational findings.
- Structural analysis of HtrA2 and its interactions.
Main Results:
- Demonstrated that allostery significantly regulates HtrA2 activity.
- Identified a novel, non-canonical selective binding pocket in HtrA2.
- Characterized a complex allosteric mechanism initiating signal propagation to the active site.
Conclusions:
- HtrA2 activity is controlled by a unique allosteric mechanism involving a non-classical binding pocket.
- This discovery reveals a novel regulatory pathway for HtrA2, distinct from other HtrA family members.
- Understanding this mechanism opens new avenues for therapeutic interventions targeting HtrA2 in diseases like cancer and neurodegeneration.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Allosteric Regulation
Allosteric Regulation
Ligand Binding and Linkage
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Cooperative Allosteric Transitions

